Zydus Life noted that population-scale studies show high rates of bone involvement, affecting 50-70% of advanced breast or ...
Patent Protects Novel Application of Gedeptin Therapy Across Multiple Solid Tumor Types; Supports Expansion of Gedeptin ...
Cancer drug developer Immutep has landed a major offshore commercialisation deal worth $30 million upfront and as much as ...
Dr. Reddy’s Laboratories is paying $20 million upfront for the rights to Immutep’s phase 3-stage LAG-3 candidate in certain ...
Sydney-based Immutep and Dr Reddy’s Laboratories have inked an exclusive licensing agreement through their arms for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback